- South Korea
- /
- Life Sciences
- /
- KOSDAQ:A043090
TechnologyLtd Full Year 2024 Earnings: ₩219 loss per share (vs ₩433 loss in FY 2023)
TechnologyLtd (KOSDAQ:043090) Full Year 2024 Results
Key Financial Results
- Revenue: ₩10.4b (down 31% from FY 2023).
- Net loss: ₩15.8b (loss narrowed by 35% from FY 2023).
- ₩219 loss per share (improved from ₩433 loss in FY 2023).
All figures shown in the chart above are for the trailing 12 month (TTM) period
TechnologyLtd's share price is broadly unchanged from a week ago.
Risk Analysis
You still need to take note of risks, for example - TechnologyLtd has 4 warning signs we think you should be aware of.
Valuation is complex, but we're here to simplify it.
Discover if TechnologyLtd might be undervalued or overvalued with our detailed analysis, featuring fair value estimates, potential risks, dividends, insider trades, and its financial condition.
Access Free AnalysisHave feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
About KOSDAQ:A043090
TechnologyLtd
Manufactures and distributes pharmaceutical raw materials, healthcare products, and cosmetics in South Korea.
Adequate balance sheet slight.
Market Insights
Community Narratives

